- Home
- About Us
- Service
- Application
- Technology
- Contact Us
Biopharma Serives
Powering Precision Medicine & Drug Discovery
HaploX provides a range of services, from the initial genotypic screening of subjects to the analysis of clinical and genomic data, including genetic screening for patient enrollment, biomarker discovery, co-development of companion diagnostic, research & academic cooperation and marketing activity collaboration. R&D genetic testing solutions aim to better meet the needs of collaborative clients in drug development and scientific research.
As of now, HaploX has provided our research and development genetic testing services to over 700 biopharmaceutical companies, research institutes and other institutions. We look forward to offering 'precision' services to more biopharmaceutical companies and research institutions in the future, as well as facilitating the translation of these research findings into novel clinical applications to optimize cancer care.
Services
Core Service Values
Excellence in Quality, Relentless Pursuit
Strategic Partnerships
Partnered with over 100 pharmaceutical companies and leveraging expertise from more than 200 projects. Our project portfolio spans a wide range of drug and therapeutic modalities—including small molecules, antibody–drug conjugates (ADCs), bispecific antibodies, mRNA, tumor neoantigens, and cell & gene therapies (CGT).
Small molecules
Neoantigen vaccines
Antibody/Antibody–drug conjugates (ADC) drugs
Cell & gene therapies (CGT)
Address
Units 610, 6/F, Building 16W, Phase 3, HongKong Science Park, New Territories, HongKong
Phone
+852 69410851
customer_service@haplox.net
© Copyright Job Portal 2025.
